abentang pills

Aspirin can inhibit the synthesis of prostaglandins and has antipyretic and analgesic effects; phenobarbital is a central nervous system depressant with sedative, hypnotic and anticonvulsant effects.

Each pill of this product contains 25 mg of aspirin and 2.5 mg of phenobarbital.

This product is a white sugar pill; it tastes sweet first and then sour.

Used for antipyretic, analgesic and sedative in children under 6 years old.

Pediatric dosage: 2-3 years old, 12-14 kg, 2-4 tablets/time. 4-6 years old, 16-20 kg, 4-8 tablets/time. If symptoms do not improve, repeat the medication every 4-6 hours, no more than 4 times in 24 hours.

The more common adverse reactions are nausea, vomiting, upper abdominal discomfort or pain. Less common adverse reactions are bronchospasm and allergic reactions. Occasionally, there are rashes, urticaria, and skin itching.

Patients who are allergic to any of the ingredients in this product are prohibited from using this product. Patients with respiratory depression and porphyria are prohibited from using this product. Patients with wheezing, nasal polyposis syndrome, allergies to aspirin and other antipyretic analgesics are prohibited from using this product. Patients with hemophilia, thrombocytopenia, and active bleeding diseases are prohibited from using this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

It should not be used with other central nervous system depressants. It should not be used with anticoagulants such as dicoumarol and heparin. If you are taking other medicines, please consult a doctor or pharmacist before using this product.

Keep sealed.

Aspirin 25 mg, phenobarbital 2.5 mg

24 months

Liaoyuan Yulongyadong Pharmaceutical Co., Ltd.

• Founded in:

  1999-08-03

• Address:

  No. 5 Yiyang, Youyi Road, Longshan District, Liaoyuan City (South side of Yijian Road Crossing)

• Tax NO.:

  912204007171163934

• Registered Funds:

  17.303 million yuan

• Website:

  Log in to view

• Email:

  Log in to view